Kynam Capital (VERA) now holds 4.01% beneficial stake in Vera Therapeutics

Rhea-AI Filing Summary

Kynam Capital Management, LP, Kynam Capital Management GP, LLC and Yue Tang report beneficial ownership of Vera Therapeutics, Inc. Class A common stock. They have shared voting and dispositive power over 2,890,059 shares, representing 4.01% of the class, and state ownership of 5 percent or less of the class.

Key Figures

Shares beneficially owned: 2,890,059 shares Percent of class: 4.01 % Sole voting power: 0 shares +3 more

6 metrics

Shares beneficially owned 2,890,059 shares Class A common stock with shared voting and dispositive power

Percent of class 4.01 % Ownership percentage of Vera Therapeutics Class A common stock

Sole voting power 0 shares Shares over which reporting persons have sole voting power

Shared voting power 2,890,059 shares Shares over which reporting persons have shared voting power

Sole dispositive power 0 shares Shares over which reporting persons have sole dispositive power

Shared dispositive power 2,890,059 shares Shares over which reporting persons have shared dispositive power

Key Terms

beneficially owned, shared voting power, shared dispositive power, Ownership of 5 percent or less of a class, +1 more

5 terms

beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned: 0 (b) | Percent of class: 4.01 %"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared voting power financial

"Shared Voting Power 2,890,059.00 7 | Sole Dispositive Power 0.00 8 | Shared Dispositive Power 2,890,059.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Shared Voting Power 2,890,059.00 7 | Sole Dispositive Power 0.00 8 | Shared Dispositive Power 2,890,059.00"

Ownership of 5 percent or less of a class financial

"Item 5. | Ownership of 5 Percent or Less of a Class. | Ownership of 5 percent or less of a class"

Schedule 13G regulatory

"Ownership of 5 Percent or Less of a Class. | Ownership of 5 percent or less of a class"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

What stake in Vera Therapeutics (VERA) does Kynam Capital report in this Schedule 13G/A?

Kynam Capital and related filers report beneficial ownership of 2,890,059 shares of Vera Therapeutics Class A common stock, representing 4.01% of the class, with shared voting and dispositive power over those shares.

Who are the reporting persons in the Vera Therapeutics (VERA) Schedule 13G/A?

The reporting persons are Kynam Capital Management, LP, Kynam Capital Management GP, LLC, and Yue Tang. All three report shared voting and dispositive power over the same 2,890,059 Vera Therapeutics Class A shares.

What level of voting power does Kynam Capital have in Vera Therapeutics (VERA)?

Kynam Capital and the other reporting persons report 0 shares with sole voting power and 2,890,059 shares with shared voting power in Vera Therapeutics Class A common stock, corresponding to 4.01% of the class.

Does Kynam Capital still own 5% or more of Vera Therapeutics (VERA)?

No. The filing states that the reporting persons have ownership of 5 percent or less of Vera Therapeutics’ Class A common stock, with their reported stake at 4.01% of the class.

What dispositive power over Vera Therapeutics (VERA) shares is reported by Kynam Capital?

The reporting persons disclose 0 shares with sole dispositive power and 2,890,059 shares with shared dispositive power in Vera Therapeutics Class A common stock, matching their shared voting power over the same shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 12:16 PM Accepted by SEC EDGAR 08/14/2026 - 12:16 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Vera Therapeutics, Inc.

(Name of Issuer)

Class A common stock, $0.001 par value per share

(Title of Class of Securities)

92337R101

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 92337R101

1

Names of Reporting Persons

Kynam Capital Management, LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,890,059.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,890,059.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.01 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 92337R101

1

Names of Reporting Persons

Kynam Capital Management GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,890,059.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,890,059.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.01 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 92337R101

1

Names of Reporting Persons

Yue Tang

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,890,059.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,890,059.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.01 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Vera Therapeutics, Inc.
(b)	Address of issuer's principal executive offices: 2000 Sierra Point Parkways, Suite 1200, Brisbane, CALIFORNIA 94005
Item 2.
(a)	Name of person filing: Kynam Capital Management, LP Kynam Capital Management GP, LLC Yue Tang
(b)	Address or principal business office or, if none, residence: 221 ELM ROAD PRINCETON, New Jersey 08540
(c)	Citizenship: Kynam Capital Management, LP - DELAWARE Kynam Capital Management GP, LLC - DELAWARE Yue Tang - UNITED STATES
(d)	Title of class of securities: Class A common stock, $0.001 par value per share
(e)	CUSIP No.: 92337R101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0
(b)	Percent of class: 4.01 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Kynam Capital Management, LP - 0 Kynam Capital Management GP, LLC - 0 Yue Tang - 0
	(ii) Shared power to vote or to direct the vote: Kynam Capital Management, LP - 2,890,059 Kynam Capital Management GP, LLC - 2,890,059 Yue Tang - 2,890,059
	(iii) Sole power to dispose or to direct the disposition of: Kynam Capital Management, LP - 0 Kynam Capital Management GP, LLC - 0 Yue Tang - 0
	(iv) Shared power to dispose or to direct the disposition of: Kynam Capital Management, LP - 2,890,059 Kynam Capital Management GP, LLC - 2,890,059 Yue Tang - 2,890,059
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Kynam Capital Management, LP

Signature:	Yue Tang
Name/Title:	Managing Member
Date:	08/14/2026

Kynam Capital Management GP, LLC

Signature:	Yue Tang
Name/Title:	Managing Member
Date:	08/14/2026

Yue Tang

Signature:	Yue Tang
Name/Title:	Self
Date:	08/14/2026